Ignite Creation Date:
2024-05-06 @ 8:54 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02855268
Status:
TERMINATED
Last Update Posted:
2023-10-23
First Post:
2016-07-28
Brief Title:
Study of Lademirsen SAR339375 in Patients With Alport Syndrome
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
ACT16248
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None